Receptor Mechanisms of Antipsychotic Drug Action in Bipolar Disorder – Focus on Asenapine

Therapeutic Advances in Psychopharmacology
doi 10.1177/2045125311430112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Bipolar Disorder and Mechanisms of Action of Mood Stabilizers

Brain Research Reviews
2009English

Asenapine in Bipolar I Disorder: Evidence and Place in Patient Management

Therapeutic Advances in Chronic Disease
Medicine
2012English

Asenapine Treatment in Pediatric Patients With Bipolar I Disorder or Schizophrenia: A Review

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2017English

Bipolar Disorder: Leads From the Molecular and Cellular Mechanisms of Action of Mood Stabilisers

British Journal of Psychiatry
MedicinePsychiatryMental Health
2001English

Antiepileptic Drug Mechanisms of Action

Epilepsia
Neurology
1993English

Patient Perspectives on Use of Long-Acting Antipsychotics in Bipolar Disorder: Focus on Risperidone Injection

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2010English

Treatment Options in Bipolar Disorder: Lessons From Population-Based Registers With Focus on Lithium

Current Treatment Options in Psychiatry
PsychiatryClinical PsychologyMental Health
2015English

Physical Activity for Bipolar Disorder: Clinical Outcomes and Mechanisms of Action Chair: Beny Lafer, Karla M. Almeida

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2019English

Comparison of Somnolence Associated With Asenapine, Olanzapine, Risperidone, and Haloperidol Relative to Placebo in Patients With Schizophrenia or Bipolar Disorder

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy